ACM
ANRO icon

Accent Capital Management’s Alto Neuroscience ANRO Stock Holding History

Accent Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.18K Buy
+275
New +$5.1K ﹤0.01% 257

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Accent Capital Management's ANRO Position: Q1 2026 in Review

Accent Capital Management opened a new position in Alto Neuroscience (ANRO) in Q1 2026: 275 shares worth $6.18K. The stake represents ﹤0.01% of the portfolio and ranks #257 among its holdings.

110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Accent Capital Management held 275 shares of Alto Neuroscience worth $6.18K as of Q1 2026.
  • Alto Neuroscience was a new Accent Capital Management position in Q1 2026.
  • Alto Neuroscience made up ﹤0.01% of Accent Capital Management's portfolio in Q1 2026, its #257 holding.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.